Home › Funds › PNC Financial Services › OCUL
PNC Financial Services position in OCUL
OCULAR THERAPEUTIX INC · Health Care
Latest position (Q2 2026)957 sh
Reported value held$9.40K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 1.00K | $7.00K | New |
| Q4 2023 | 11 | $49 | New |
| Q1 2024 | 122 | $1.11K | Add |
| Q2 2024 | 106 | $725 | Reduce |
| Q1 2025 | 283 | $2.07K | New |
| Q2 2025 | 511 | $4.74K | Add |
| Q3 2025 | 726 | $8.49K | Add |
| Q4 2025 | 682 | $8.28K | Reduce |
| Q1 2026 | 609 | $5.16K | Reduce |
| Q2 2026 | 957 | $9.40K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding OCUL
- Fidelity Management & Research (FMR) 32.84M sh · $322.53M · Q2 2026
- BlackRock Inc 19.38M sh · $190.28M · Q2 2026
- Vanguard Group 11.58M sh · $140.52M · Q4 2025
- Geode Capital Management 5.02M sh · $49.32M · Q2 2026
- Point72 Asset Management 3.29M sh · $32.33M · Q2 2026
- Balyasny Asset Management 3.25M sh · $31.87M · Q2 2026
- Northern Trust Corp 1.80M sh · $17.67M · Q2 2026
- Goldman Sachs Group 1.76M sh · $17.30M · Q2 2026
- UBS Group AG 1.55M sh · $15.23M · Q2 2026
- Charles Schwab Investment Management 1.53M sh · $15.06M · Q2 2026
- Invesco Ltd 1.34M sh · $13.20M · Q2 2026
- Two Sigma Investments 1.22M sh · $11.97M · Q2 2026